LAUREN MAJOR: Open Payments
NPI 1336924273 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,875 in 48 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $374 · 2025 $2,875
Food & beverage: $2,137Consulting: $633Education: $79Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $1,322 |
| AstraZeneca Pharmaceuticals LP | 23 | $1,130 |
| Amgen Inc. | 10 | $207 |
| Verona Pharma, Inc. | 1 | $137 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
Products named: TEZSPIRE, DUPIXENT, Ohtuvayre, BREZTRI, AIRSUPRA, FASENRA, LUMIZYME.
Industry payments across MA — which companies pay providers there.
